WAKE FOREST UNIVERSITY HEALTH SCIENCES

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Mobility Assessment Using Surrogates in Elderly Participants

Completed

Conditions: Mobility Limitation

First Posted Date: 2017-01-26

Last Posted Date: 2017-12-05

Lead Sponsor: Wake Forest University Health Sciences

Target Recruit Count: 130

Registration Number: NCT03032341

Locations: 🇺🇸
Wake Forest University Health Sciences, Winston-Salem, North Carolina, United States

Vitamin D Deficiency and Dysautonomia

Not Applicable

Completed

Conditions: Nausea
Vitamin D Deficiency
Orthostatic Intolerance

Interventions: Dietary Supplement: vitamin D supplement

First Posted Date: 2017-01-26

Last Posted Date: 2023-01-27

Lead Sponsor: Wake Forest University Health Sciences

Target Recruit Count: 31

Registration Number: NCT03032328

Locations: 🇺🇸
Wake Forest Baptist Health, Winston-Salem, North Carolina, United States

Video vs. Direct Laryngoscopy in Pediatric Nasal Intubation

Not Applicable

Terminated

Conditions: Nasal Intubation

Interventions: Device: Direct Laryngoscopy
Device: Video Laryngoscopy for nasal intubation

First Posted Date: 2017-01-26

Last Posted Date: 2018-08-08

Lead Sponsor: Wake Forest University Health Sciences

Target Recruit Count: 12

Registration Number: NCT03032263

Locations: 🇺🇸
Wake Forest University Health Sciences, Winston-Salem, North Carolina, United States

Biologics Anchoring Study

Not Applicable

Completed

Conditions: Moderate-to-severe Psoriasis

Interventions: Behavioral: Intervention Group Oral Survey 2
Behavioral: Control Group Oral Survey 1

First Posted Date: 2017-01-20

Last Posted Date: 2018-06-11

Lead Sponsor: Wake Forest University Health Sciences

Target Recruit Count: 100

Registration Number: NCT03026153

Locations: 🇺🇸
Dept of Dermatology, WFUHS, Winston-Salem, North Carolina, United States

Pilot Study of Paclitaxel Plus Pembrolizumab in Metastatic HER2-Negative Breast Cancer

Phase 2

Completed

Conditions: Breast - Female
Male Breast Cancer

Interventions: Drug: Pembrolizumab
Drug: Paclitaxel

First Posted Date: 2017-01-11

Last Posted Date: 2023-08-04

Lead Sponsor: Wake Forest University Health Sciences

Target Recruit Count: 40

Registration Number: NCT03018080

Locations: 🇺🇸
Levine Cancer Institute, Charlotte, North Carolina, United States

Efficacy of Intrathecal Oxytocin to Speed Recovery After Hip Surgery

Phase 2

Terminated

Conditions: Postoperative Pain

Interventions: Drug: Placebo
Drug: Oxytocin

First Posted Date: 2017-01-05

Last Posted Date: 2022-11-23

Lead Sponsor: Wake Forest University Health Sciences

Target Recruit Count: 126

Registration Number: NCT03011307

Locations: 🇺🇸
Wake Forest Baptist Medical Center, Winston-Salem, North Carolina, United States

IINB vs. QLB for Elective Open Inguinal Herniorrhaphy

Phase 2

Completed

Conditions: Nerve Block
Herniorrhaphy
Regional Anesthesia

Interventions: Procedure: Ilioinguinal / Iliohypogastric Block
Procedure: Quadratus Lumborum Block
Drug: Bupivacaine 0.25%
Drug: Clonidine 1.66mcg/cc

First Posted Date: 2017-01-02

Last Posted Date: 2019-11-18

Lead Sponsor: Wake Forest University Health Sciences

Target Recruit Count: 60

Registration Number: NCT03007966

Locations: 🇺🇸
Wake Forest Baptist Medical Center, Winston-Salem, North Carolina, United States

Single Injection Adductor Canal Block Versus Continuous Adductor Canal Infusion for Total Knee Arthroplasty

Early Phase 1

Completed

Conditions: Total Knee Arthroplasty
Pain, Postoperative
Adductor Canal Block

Interventions: Procedure: Multimodal Peripheral Nerve Block Injection
Procedure: Single Shot Adductor Canal Block
Drug: Initial Bolus
Drug: Continuous infusion

First Posted Date: 2016-12-13

Last Posted Date: 2018-04-05

Lead Sponsor: Wake Forest University Health Sciences

Target Recruit Count: 60

Registration Number: NCT02991404

Locations: 🇺🇸
Wake Forest Baptist Hospital, Winston-Salem, North Carolina, United States

Genomic Outcomes of Metformin

Phase 4

Completed

Conditions: Coronary Artery Disease
Mild Cognitive Impairment
Obesity, Abdominal
Hypertension

Interventions: Drug: Metformin
Drug: Placebo

First Posted Date: 2016-12-08

Last Posted Date: 2023-11-18

Lead Sponsor: Wake Forest University Health Sciences

Target Recruit Count: 30

Registration Number: NCT02986659

Locations: 🇺🇸
Wake Forest Health Sciences, Winston-Salem, North Carolina, United States

Effect of a Modified Ketogenic-Mediterranean Diet on Alzheimer's Disease

Not Applicable

Completed

Conditions: Mild Cognitive Impairment
Insulin Resistance

Interventions: Other: Low-Fat Diet
Other: Low-Carbohydrate Diet

First Posted Date: 2016-12-07

Last Posted Date: 2020-08-04

Lead Sponsor: Wake Forest University Health Sciences

Target Recruit Count: 25

Registration Number: NCT02984540

Locations: 🇺🇸
Wake Forest Baptist Health, Winston-Salem, North Carolina, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy